Kula Investments’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Kula Investments's RPRX Position: Q1 2023 in Review
Kula Investments reduced its Royalty Pharma (RPRX) stake by 22% in Q1 2023, selling an estimated $148K and leaving 14,454 shares worth $521K. The position accounts for 0.13% of the portfolio, ranked #292.
Kula Investments first reported a position in RPRX in Q4 2022 and has held it in 2 quarters since. The position peaked at $729K in Q4 2022. 335 funds tracked by Wall St. Rank hold RPRX as of Q1 2023.
- Kula Investments held 14,454 shares of Royalty Pharma worth $521K as of Q1 2023.
- Kula Investments sold 4,002 Royalty Pharma shares in Q1 2023, an estimated $148K.
- Royalty Pharma made up 0.13% of Kula Investments's portfolio in Q1 2023, its #292 holding.
- Kula Investments first reported a position in Royalty Pharma in Q4 2022 and has held it in 2 quarters since.
- Kula Investments's Royalty Pharma position peaked at $729K in Q4 2022.
- 335 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2023.
Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.